(Q34893595)

5 August 2017

1 reference

title

Comparison of carbamazepine and lithium in treatment of bipolar disorder: a systematic review of randomized controlled trials (English)

1 reference

5 August 2017

1 reference

1 reference

1 reference

Daniela Ceron-Litvoc

1

1 reference

5 August 2017

Bernardo Garcia Soares

2

1 reference

5 August 2017

John Geddes

3

1 reference

5 August 2017

Julio Litvoc

4

1 reference

5 August 2017

Mauricio Silva de Lima

5

1 reference

5 August 2017

1 January 2009

1 reference

5 August 2017

Human Psychopharmacology

1 reference

5 August 2017

24

1 reference

5 August 2017

1

1 reference

5 August 2017

19-28

1 reference

Identifying relevant studies for systematic reviews

5 August 2017

1 reference

Carbamazepine compared to haloperidol in acute mania

21 January 2018

1 reference

7 January 2021

Locating and appraising systematic reviews

1 reference

7 January 2021

Optimal search strategy for clinical trials in the Latin American and Caribbean Health Science Literature Database (LILACS).

1 reference

7 January 2021

Carbamazepine versus lithium in the prophylaxis of bipolar affective disorder

1 reference

7 January 2021

Comparison of carbamazepine and lithium in the prophylaxis of bipolar disorders. A meta-analysis

1 reference

7 January 2021

Mood stabilizers in the prevention of recurrent affective disorders: a meta-analysis

1 reference

7 January 2021

Comparative prophylactic efficacy of lithium, carbamazepine, and the combination in bipolar disorder.

1 reference

7 January 2021

What is a mood stabilizer?

1 reference

7 January 2021

Differential response to lithium and carbamazepine in the prophylaxis of bipolar disorder

1 reference

7 January 2021

Lithium versus carbamazepine in the maintenance treatment of bipolar disorders--a randomised study

1 reference

7 January 2021

Prophylactic efficacy of lithium versus carbamazepine in treatment-naive bipolar patients.

1 reference

7 January 2021

Screening for bipolar disorder in the community

1 reference

7 January 2021

A review of the evidence for carbamazepine and oxcarbazepine in the treatment of bipolar disorder

1 reference

7 January 2021

Carbamazepine in psychiatry: a review

1 reference

7 January 2021

Systematic reviews and meta-analyses on treatment of asthma: critical evaluation

1 reference

7 January 2021

Differential efficacy of lithium and carbamazepine in the prophylaxis of bipolar disorder: results of the MAP study

1 reference

7 January 2021

Inter-episodic morbidity and drop-out under carbamazepine and lithium in the maintenance treatment of bipolar disorder

1 reference

7 January 2021

Effect size of lithium, divalproex sodium, and carbamazepine in children and adolescents with bipolar disorder

1 reference

7 January 2021

Use of carbamazepine in acute psychosis: a controlled study

1 reference

7 January 2021

Carbamazepine vs lithium in the treatment and prophylaxis of mania

1 reference

7 January 2021

Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study

1 reference

7 January 2021

Comparison of the antimanic efficacy of carbamazepine and chlorpromazine: A double-blind controlled study

1 reference

7 January 2021

A preliminary double-blind study on the efficacy of carbamazepine in prophylaxis of manic-depressive illness

1 reference

7 January 2021

Comparison of the antimanic efficacy of carbamazepine and lithium carbonate by double-blind controlled study.

1 reference

7 January 2021

Antidepressant effects of carbamazepine

1 reference

7 January 2021

Potentiation of antidepressants with lithium or carbamazepine in treatment-resistant depression.

1 reference

7 January 2021

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

1 reference

7 January 2021

The comparative efficacy of carbamazepine low and high serum level and lithium carbonate in the prophylaxis of affective disorders

1 reference

7 January 2021

Carbamazepine compared with lithium in the treatment of mania

1 reference

7 January 2021

Effectiveness of mood stabilizers and antipsychotics in the maintenance phase of bipolar disorder: a systematic review of randomized controlled trials.

1 reference

7 January 2021

Pharmacological interventions for acute bipolar mania: a systematic review of randomized placebo-controlled trials

1 reference

7 January 2021

Historical review of carbamazepine for the treatment of bipolar disorder

1 reference

7 January 2021

Carbamazepine and valproate monotherapy: feasibility, relative safety and efficacy, and therapeutic drug monitoring in manic disorder

1 reference

7 January 2021

The effect of carbamazepine and lithium on remission from affective illness

1 reference

7 January 2021

A multicenter, randomized, double-blind, placebo-controlled trial of extended-release carbamazepine capsules as monotherapy for bipolar disorder patients with manic or mixed episodes.

1 reference

7 January 2021

Extended-release carbamazepine capsules as monotherapy for acute mania in bipolar disorder: a multicenter, randomized, double-blind, placebo-controlled trial.

1 reference

7 January 2021

Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: update 2007.

1 reference

7 January 2021

Treatment of bipolar affective disorder

1 reference

7 January 2021

Adjunctive herbal medicine with carbamazepine for bipolar disorders: A double-blind, randomized, placebo-controlled study

1 reference

7 January 2021

Identifiers

DOI

10.1002/HUP.990

1 reference

5 August 2017

1 reference